These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 27614073)
41. Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma. Tiedemann RL; Hlady RA; Hanavan PD; Lake DF; Tibes R; Lee JH; Choi JH; Ho TH; Robertson KD Oncotarget; 2016 Jan; 7(2):1927-46. PubMed ID: 26646321 [TBL] [Abstract][Full Text] [Related]
42. SETD2-mediated H3K14 trimethylation promotes ATR activation and stalled replication fork restart in response to DNA replication stress. Zhu Q; Yang Q; Lu X; Wang H; Tong L; Li Z; Liu G; Bao Y; Xu X; Gu L; Yuan J; Liu X; Zhu WG Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34074749 [TBL] [Abstract][Full Text] [Related]
44. SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. Bu J; Chen A; Yan X; He F; Dong Y; Zhou Y; He J; Zhan D; Lin P; Hayashi Y; Sun Y; Zhang Y; Xiao Z; Grimes HL; Wang QF; Huang G Leukemia; 2018 Apr; 32(4):890-899. PubMed ID: 29249820 [TBL] [Abstract][Full Text] [Related]
45. SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12. González-Rodríguez P; Engskog-Vlachos P; Zhang H; Murgoci AN; Zerdes I; Joseph B Cell Death Dis; 2020 Jan; 11(1):69. PubMed ID: 31988284 [TBL] [Abstract][Full Text] [Related]
46. Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts. Yi X; Tao Y; Lin X; Dai Y; Yang T; Yue X; Jiang X; Li X; Jiang DS; Andrade KC; Chang J Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):697-707. PubMed ID: 28130125 [TBL] [Abstract][Full Text] [Related]
47. The disordered regions of the methyltransferase SETD2 govern its function by regulating its proteolysis and phase separation. Bhattacharya S; Lange JJ; Levy M; Florens L; Washburn MP; Workman JL J Biol Chem; 2021 Sep; 297(3):101075. PubMed ID: 34391778 [TBL] [Abstract][Full Text] [Related]
48. Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma. Li J; Kluiver J; Osinga J; Westers H; van Werkhoven MB; Seelen MA; Sijmons RH; van den Berg A; Kok K Neoplasia; 2016 Jun; 18(6):339-46. PubMed ID: 27292023 [TBL] [Abstract][Full Text] [Related]
49. Shaping the cellular landscape with Set2/SETD2 methylation. McDaniel SL; Strahl BD Cell Mol Life Sci; 2017 Sep; 74(18):3317-3334. PubMed ID: 28386724 [TBL] [Abstract][Full Text] [Related]
50. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231 [TBL] [Abstract][Full Text] [Related]
51. The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice. Zuo X; Rong B; Li L; Lv R; Lan F; Tong MH J Biol Chem; 2018 Jun; 293(24):9188-9197. PubMed ID: 29716999 [TBL] [Abstract][Full Text] [Related]
52. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT. Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383 [TBL] [Abstract][Full Text] [Related]
53. Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase. Lam UTF; Chen ES Int J Biochem Cell Biol; 2022 Mar; 144():106155. PubMed ID: 34990836 [TBL] [Abstract][Full Text] [Related]
54. Chiang YC; Park IY; Terzo EA; Tripathi DN; Mason FM; Fahey CC; Karki M; Shuster CB; Sohn BH; Chowdhury P; Powell RT; Ohi R; Tsai YS; de Cubas AA; Khan A; Davis IJ; Strahl BD; Parker JS; Dere R; Walker CL; Rathmell WK Cancer Res; 2018 Jun; 78(12):3135-3146. PubMed ID: 29724720 [TBL] [Abstract][Full Text] [Related]
55. The histone methyltransferase SETD2 regulates HIV expression and latency. Bussey-Sutton CR; Ward A; Fox JA; Turner AW; Peterson JJ; Emery A; Longoria AR; Gomez-Martinez I; Jones C; Hepperla A; Margolis DM; Strahl BD; Browne EP PLoS Pathog; 2024 Jun; 20(6):e1012281. PubMed ID: 38848441 [TBL] [Abstract][Full Text] [Related]
56. Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis. Yuan H; Li N; Fu D; Ren J; Hui J; Peng J; Liu Y; Qiu T; Jiang M; Pan Q; Han Y; Wang X; Li Q; Qin J J Clin Invest; 2017 Sep; 127(9):3375-3391. PubMed ID: 28825595 [TBL] [Abstract][Full Text] [Related]
57. SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2. Wang J; Zhuang H; Zhang H; Li Q; Cao X; Lin Z; Lin T; Chen X; Ni X; Yang J; Zhao Y; Shen L; Wang H; Zhu J; Ye M; Jin X Biochem Biophys Res Commun; 2021 Jun; 557():55-61. PubMed ID: 33862460 [TBL] [Abstract][Full Text] [Related]
58. Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP-HIPK2 axis. Jin X; Qing S; Li Q; Zhuang H; Shen L; Li J; Qi H; Lin T; Lin Z; Wang J; Cao X; Yang J; Ma Q; Cong L; Xi Y; Fang S; Meng X; Gong Z; Ye M; Wang S; Wang C; Gao K Nucleic Acids Res; 2021 Jul; 49(12):6788-6803. PubMed ID: 34133717 [TBL] [Abstract][Full Text] [Related]
59. Histone and RNA-binding protein interaction creates crosstalk network for regulation of alternative splicing. Kim YE; Park C; Kim KE; Kim KK Biochem Biophys Res Commun; 2018 Apr; 499(1):30-36. PubMed ID: 29551686 [TBL] [Abstract][Full Text] [Related]
60. Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma. Bihr S; Ohashi R; Moore AL; Rüschoff JH; Beisel C; Hermanns T; Mischo A; Corrò C; Beyer J; Beerenwinkel N; Moch H; Schraml P Neoplasia; 2019 Feb; 21(2):247-256. PubMed ID: 30660076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]